ArticleGene therapy2006

Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashi1 promoter retargeting of gamma34.5-mediated virulence.

R Kanai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.